The funding panels for SBRI Healthcare are multidisciplinary, comprising clinical, commercial and technical expertise as well as representatives from the Academic Health Science Networks (AHSN) and Innovate UK.
The funding panel for the Phase 2 Cardiovascular Disease competition follows:
| Professor Michael Lewis (Chair) | Non Executive Chairman, iPlato Ltd | Professor Michael Lewis is Chair of five Medical/CRO/digital health companies and Professor at Birmingham Medical School. His industry experience covers pharma, biotech, digital, dental, devices and diagnostics and he is also Chair of the Biocatalyst Major Awards (MAC2) Panel. |
| Dr Philip Jennings | Medical Director, Innovation Agency NWC | Phil is Medical Director for the Innovation Agency NWC, while continuing to practise as a freelance GP in Merseyside, with a specialist interest in cardiology. He was previously the primary care lead for the Cheshire and Merseyside Cardiac Network. |
| Professor Paul Leeson | Head of Oxford Cardiovascular Clinical Research Facility, University of Oxford | Paul is Professor of Cardiovascular Medicine at the University of Oxford, Research Fellow at Wolfson College and Head of the Oxford Cardiovascular Clinical Research Facility. He is also a Consultant Cardiologist at the John Radcliffe Hospital, where he provides expertise in Cardiovascular Imaging, as well as General Cardiology and Cardiovascular Prevention through the Oxford Specialist Hypertension Clinic. |
| Mr Robin Stern | Executive Chair, Future Perfect (Healthcare) | As well as being Executive Chair of healthcare AI business Future Perfect, Robin is Non-Executive Director for healthcare technology company Medic Creations; he has board experience in digital healthcare businesses and NHS bodies; and has been Director of innovation consultancies in the health and care sector, fostering innovation and achieving huge savings and efficiencies. |
| Mr Mark Kirby | Chief Executive, SmartTarget Limited | Mark is an experienced MedTech chairman with experience of start-up to exit challenges. His specialties include strategy, fundraising, building teams and growing businesses. |
| Ms Lorna Green | Chief Operating Officer, Innovation Agency NWC | Following an early career as an NHS dietitian Lorna moved into the medtech industry. She has commercialised over 40 products and has supported SMEs to secure over £20m investment. |
| Ms Lesley Soden | Head of Innovation, Services to Industry, South London AHSN | Lesley has over 20 years’ experience in the NHS and public sector. She has worked in senior business and strategy roles in mental health and community trusts. She is Programme Director for the Innovation Theme, including industry collaborations, at the South London AHSN. |
| Mr Ian Sandison | Medical Technology Consultant | Ian spent nine years with Becton Dickinson and three with Smiths Medical. He assists medtech companies with strategy, planning and commercialisation. He works with the Eastern AHSN on their NHS Readiness events, he contributes to the Cambridge University, Judge Business School MBA programme. |
| Laura Fenner | Public Reviewer | |
| Dr Matthew Blackledge | Leader – Computational Imaging Team, Division of Radiotherapy and Imaging | |
| Professor John Cleland | Professor University of Glasgow and Imperial College / Consultant cardiologist Royal Brompton & Harefield NHSFT | |
| Mr Shiva Dindyal | Consultant vascular surgeon, Basildon and Thurrock Trust | |
| Professor John Camm | Clinical cardiology, honorary consultant cardiologist at St George’s, London |
The funding panel for the Phase 1 Cardiovascular Disease competition follows:
| Professor Michael Lewis (Chair) | Executive Chairman, iPlato Ltd | Michael is a serial entrepreneur and both public and private company chairman with 30 years of experience in medical devices, pharma and diagnostics. |
| Dr Philip Jennings | Medical Director, Innovation Agency NWC | Phil is Medical Director for the Innovation Agency NWC, while continuing to practise as a freelance GP in Merseyside, with a specialist interest in cardiology. He was previously the primary care lead for the Cheshire and Merseyside Cardiac Network. |
| Dr Tevfik Ismail | Consultant Cardiologist, Guy’s and St Thomas’ NHS Foundation Trust | Tevfik is a consultant cardiologist at Guy’s and St Thomas’ and a clinical senior lecturer at King’s College London. He has specialist interests in cardiovascular magnetic resonance imaging; heart failure; inherited and inflammatory heart muscle disease. |
| Dr Deirdre Lane | Reader in Cardiovascular Health, University of Liverpool | Deirdre’s background is in health psychology and cardiovascular epidemiology. Her areas of research include how cardiovascular disease affects patient quality of life, the management of atrial fibrillation, and stroke prevention. |
| Professor Paul Leeson | Head of Oxford Cardiovascular Clinical Research Facility, University of Oxford | Paul is Professor of Cardiovascular Medicine at the University of Oxford, Research Fellow at Wolfson College and Head of the Oxford Cardiovascular Clinical Research Facility. He is also a Consultant Cardiologist at the John Radcliffe Hospital, where he provides expertise in Cardiovascular Imaging, as well as General Cardiology and Cardiovascular Prevention through the Oxford Specialist Hypertension Clinic |
| Robin Stern | Partner, IT Health Partnership LLP | Robin is NED of a successful digital health supplier, past-CEO of an IT supplier and consultancy and past-NHS Director of Information and Clinical Effectiveness. He has led large national / local change programmes, and he turned around a failed transformation programme. |
| Stuart Revell | Managing Director, RTACS Ltd | Stuart is an industry expert, covering both commercial and technical disciplines with over 35 years of experience in advanced technology research, design, development and deployment. |
| David Connell | Senior Research Fellow, Cambridge Judge Business School | David has spent many years working in the science and technology sector. He was a cofounder of Archipelago Technology, a Cambridge company which specialises in high precision print technology. The design of the Small Business Research Initiative (SBRI) is largely based on proposals made by David. |
| Mark Kirby | Chief Executive, SmartTarget Limited | Mark is an experienced MedTech chairman with experience of start-up to exit challenges. His specialties include strategy, fundraising, building teams and growing businesses |
| Lorna Green | Chief Operating Officer, Innovation Agency NWC | Following an early career as an NHS dietitian she moved into the medtech industry. She has commercialised over 40 products and has supported SMEs to secure over £20m investment. |
| Lesley Soden | Head of Innovation, Services to Industry, South London AHSN | Lesley has over 20 years’ experience in the NHS and public sector. She has worked in senior business and strategy roles in mental health and community trusts. She is Programme Director for the Innovation Theme, including industry collaborations, at the South London AHSN. |
| Sarah Duncan | Deputy Director of Clinical Policy, NHS Improvement | |
| Hazel Harper | Senior Innovation Lead, Innovate UK | Local Government experience of 26 years covering procurement, contracting, social care, project and programme management and commissioning. Significant experience in delivering large scale health and care technology and service innovation programmes. |
| Laura Fenner | Public Reviewer | |
| Deb Smith | Public Reviewer |